Johnson and Johnson applies for emergency coronavirus vaccine use in Philippines

Published On 2021-04-05 03:30 GMT   |   Update On 2021-04-05 03:30 GMT

Manila: Drugmaker Johnson & Johnson has filed its application for emergency use authorisation of its COVID-19 vaccine in the Philippines, the country's Food and Drug Administration (FDA) chief said on Monday.

Read also: US puts JnJ in charge of plant that botched COVID vaccine, removes AstraZeneca

J&J's documents, which were submitted on Wednesday, are now under evaluation, FDA Director General Rolando Enrique Domingo told reporters. J&J, which has a single-shot coronavirus vaccine, is the seventh vaccine maker to seek approval in the Philippines.

Read also: Johnson and Johnson expands COVID-19 vaccine trial to include adolescents



Tags:    
Article Source : Reuters

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News